Jonathan Erlich

2.8k citations
55 papers · 2.3k · 2 hit papers · h-index 26

Impact in

  • Nephrology top 1%
    • Renal Diseases and Glomerulopathies
    • Chronic Kidney Disease and Diabetes
  • Hematology top 1%
    • Blood Coagulation and Thrombosis Mechanisms
    • Hemophilia Treatment and Research
    • Platelet Disorders and Treatments

Papers in

    • Acute Kidney Injury Research 7
    • Dialysis and Renal Disease Management 7
    • Chronic Kidney Disease and Diabetes 5
    • Renal Diseases and Glomerulopathies 4
    • Blood Coagulation and Thrombosis Mechanisms 18
    • Hemophilia Treatment and Research 4

Jonathan Erlich

52 papers receiving 2.2k citations

Jonathan Erlich's Hit Papers

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial 2023 · 185 citations
1850+1+2Years since publication50100150

Peers

Jonathan Erlich
Comparison fields: 5 of 108
  • Nephrology 494
  • Hematology 763
  • Internal Medicine 149
  • Genetics 252
  • Immunology 389
Replace JACK PINKHAS with:
JACK PINKHAS Israel
ALBERT BENSMAN France
Bruce A. Pussell Australia
PM Mannucci Italy
Ann L. Parke United States
Stefan Lethagen Sweden
Derek Ogston United Kingdom
Stefan Heidenreich Germany
José Delgado Alves Portugal
Kuang‐Hui Yu Taiwan
Jonathan Erlich relative to JACK PINKHAS Israel JACK PINKHAS's profile →
Citations per field
00.5×5×10×16.3×
JACK PINKHAS · 1×
Citations per year

Countries citing papers authored by Jonathan Erlich

Since Specialization
Citations

This map shows the geographic impact of Jonathan Erlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Erlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Erlich more than expected).

Fields of papers citing papers by Jonathan Erlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Erlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Erlich. The network helps show where Jonathan Erlich may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Erlich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Erlich Line = papers co-authored together Jonathan Erlich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1998242
2
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Hit paper breakdown →
2023185
3 1998181
4 2000178
5
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Hit paper breakdown →
2023160
6 1999100
7 199990
8 200286
9 200682
10 200480
11 198359
12 200055
13 202152
14
Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.
199750
15 201147
16 201645
17
Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA.
199544
18 200842
19 200440
20 199637

About Jonathan Erlich

Jonathan Erlich is a scholar working on Nephrology, Hematology, Cardiology and Cardiovascular Medicine, Immunology and Allergy and Cancer Research, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (18 papers), Acute Kidney Injury Research (7 papers), Dialysis and Renal Disease Management (7 papers), Chronic Kidney Disease and Diabetes (5 papers), Renal Diseases and Glomerulopathies (4 papers), Protease and Inhibitor Mechanisms (4 papers), Hemophilia Treatment and Research (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Nephrology (494 citations), Hematology (763 citations), Internal Medicine (149 citations), Genetics (252 citations) and Immunology (389 citations). Jonathan Erlich has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Nigel Mackman, Graham C. Parry, Thomas Luther, Peter Carmeliet, Colleen Fearns, Stephen Roger Holdsworth, Vladimir V. Kravchenko, Steven Gerondakis, Jan Bohuslav and Richard J. Ulevitch. Their work appears in journals such as Nephrology, Nephrology Dialysis Transplantation, Journal of Clinical Investigation, Journal of Psychosomatic Research and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact